Stage II colon cancer showed low budding in 234 (Bd1, 76.5%), intermediate budding in 56 (Bd2, 18.3%), and high budding in 16 cases (Bd3, 5.2%). This evidence concerns the gene DEFB1 and malignant colon neoplasm.